AGC Pharma Chemicals opens new €100 million manufacturing plant in Spain
It represents a 30% increase in the company’s production capacity and introduces a segment dedicated to highly potent active ingredients
It represents a 30% increase in the company’s production capacity and introduces a segment dedicated to highly potent active ingredients
Pioneering innovation aims to transform anticoagulant therapy and improve patient outcomes
Takeda will seek an external partner to leverage its cell therapy platform technologies
BPDCN is a challenging blood cancer with characteristics of both leukemia and lymphoma
The platform integrates artificial intelligence into a unified environment that supports optical, microCT, ultrasound, and other imaging modalities
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
Subscribe To Our Newsletter & Stay Updated